Your search:
1 result(s) in 0.04 s
-
DUKAS_183263361_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: (Left to right): Amaza Reitmeier, VP and general manager of Neuromodulation Portfolio, Ken Washington, chief technology officer for Medtronic, Rob Raike, director of research and technology for Medtronic Neuromodulation, Angie Mason, district manager, Medtronic, and Meredith Vornholt, senior director of marketing at Brain Modulation, watch live results of Parkinson’s patient John L. Lipp’s treatment with neurologist Gaurav Chattree, Stanford University (both not pictured), at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James